Glaukos Corporation (GKOS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Glaukos Corporation (GKOS) is up 16.2% since the beginning of the year. At $131 per share, GKOS is trading 11.4% below its 52-week high of $148. Investors who bought $1,000 worth of GKOS shares 5 years ago would now be looking at an investment worth $1,519.

Glaukos Corporation (GKOS) has returned 16.19% so far this year and 30.99% over the past 12 months. Looking at the last ten years, GKOS has achieved an annualized return of 16.63%, outperforming the S&P 500 Index benchmark, which averaged 13.88% per year.

Based on dividend-adjusted daily data since Jun 25, 2015, GKOS's average daily return is +0.11%, while the average monthly return is +2.27%. At this rate, an investment would double in approximately 2.6 years.

Historically, 59% of months were positive and 41% were negative. The best month was Aug 2018 with a return of +64.3%, while the worst month was Jul 2021 at -39.9%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 3 months.

On a daily basis, GKOS closed higher 52% of trading days. The best single day was Aug 29, 2018 with a return of +40.3%, while the worst single day was Feb 28, 2020 at -28.5%.

Glaukos Corporation has an annualized alpha of 13.21%, beta of 1.20, and R2 of 0.16 versus S&P 500 Index. Calculated based on daily prices since June 25, 2015.

• This stock captured 127.95% of S&P 500 Index gains and 118.06% of its losses - amplifying both gains and losses, but participating more in upside than downside.
• R2 of 0.16 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

GKOS ranks 62 for risk / return — better than 62% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Glaukos Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Glaukos Corporation was 69.57%, occurring on Mar 20, 2020. Recovery took 206 trading sessions.

The current Glaukos Corporation drawdown is 18.63%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Glaukos Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Glaukos Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.